Bioaccel Announces Solutions Challenge 2016 Semifinalist Teams

Bioaccel Announces Solutions Challenge 2016 Semifinalist Teams

Monday, November 7, 2016

Phoenix, AZ  (November 7, 2016) — BioAccel, an organization dedicated to supporting early-stage medical device and technology entrepreneurs, announced semifinalists for its premiere competition, Solutions Challenge 2016, to be held Thursday, December 1 at Phoenix Theatre.                     

                                                                      

“More than 60 competition category companies and student teams entered Solutions Challenge with the intent to solve critical healthcare needs through medical device and health care technology solutions,” said Ron King, Ph.D., BioAccel’s Chief Science Officer. “Of this very robust group of innovators, more than 30 university student teams applied on behalf public and private institutions in Arizona, as well from University of California at Irvine, an Economic Development Agency i6 program partner.”

 

Semifinalists include 15 entrepreneur with companies focused on five competition categories, and 14 university student innovation teams. These will be narrowed to five entrepreneur company finalists and 10 student team finalists to present medical innovations for potential seed funding at the Solutions Challenge Scorpion Pit, Arizona’s equivalent to the television series “Shark Tank.”

 

Teams can win up to $100,000 in seed funding based on decisions made by nine “Scorpion” judges who agree to invest a minimum of $10,000 in seed funding.

 

BioAccel’s Scorpion Pit judges include medical device executives and investors who are willing to invest in early-stage, innovative companies solving healthcare issues. Participants must convince the Scorpions to invest in their company, with BioAccel possibly providing up to $50,000 in matching funds. All teams obtain valuable feedback and mentoring important to launching a successful medical device or technology company based in Arizona.

 

Competition categories include the following areas of where opportunity for health innovation is notable:

  • Digital, Wearable and Mobile Health – Sponsored by Life365
  • Regents Rivalry Award for Students – Sponsored by Medtronic
  • Coordinated Care – Sponsored by Celgene
  • Novel Medical Devices sponsored by Molded Devices
  • Early Diagnosis Tools for Dementia

 

Tickets and sponsor information for the Solutions Challenge Scorpion Pit competition and award reception are on online at http://bit.ly/2exaHWF.

 

All team applications were vetted through a rigorous assessment process. The following teams were selected as semifinalists. 

 

Competition category and student  semifinalist teams for BioAccel’s Solutions Challenge 2016

 

Competition Category 1: Digital, Wearable and Mobile Health – Sponsored by Life365

 

eVisit

eVisit® is a telemedicine software platform for medical practices and health systems. The company’s product allows physicians, nurse practitioners, and physician assistants to diagnose patient conditions remotely through high-resolution, two-way video. The product provides physicians with the ability to collect payment and electronically prescribe treatment to more than 66,000 pharmacies nationwide. Unlike competitors, eVisit software is the only solution with a medical billing engine built-in. The system calculates and collects patient co-pays, and creates a patient medical chart to be submitted for reimbursement from third-party payers.

 

OWAS

OWAS provides a smart questionnaire for patients and their families to identify cases of mild cognitive impairment, available for use on a smart phone or tablet computer web browser.   The questionnaire incorporates the Medicare Annual Wellness Visit Algorithm for Assessment of Cognition. 

 

LinkX

LinkX is a mobile optimized web app for patients and providers offering quick, convenient online searches to display cash pricing and medication availability from local pharmacies. LinkX provides this information at the point of care, increasing efficiency and avoiding frustrating situations for the consumer. LinkX empowers patients and providers with accurate, reliable information and improves coordination of care between multiple health entities through a network of community pharmacy partners.

 

TunHub 

TunHub is an online laboratory and marketplace for industry and university scientists who conduct research. TunHub virtualizes and improves all research processes and converts findings into e-health apps. The product covers the full psychological experiment research process, participant management and payment and coding. TunHub’s core purpose is to make research faster and better and automatically create e-health and business products out of scientific findings.

 

HER Inc - SkinSAFE

SkinSAFE is a web and mobile “transparency and analytics” platform for beauty, skin care and household products. SkinSAFE offers detailed product information and a first-of-its-kind ingredient scoring system to provide consumers with the knowledge and power needed to make buying decisions. Clients include health conscious consumers and skin allergy sufferers, physicians and skin health professionals, and all general consumers.

Better ON Call

Better ON Call is a digital, mobile health company aiming to bring back the traditional doctor house call using a mobile application. Better ON Call plans to disrupt the current healthcare model by allowing patients to choose their physician, when they will see them, all from the comfort of their home, hotel, or workplace. The company will keep patient information on a HIPAA-compliant cloud-based server to ensure that only authorized physicians and the patient themselves are able to store, decipher, and access their health record.

 

Competition Category 2: Coordinated Care – Sponsored by Celgene

 

PHR+

PHR+ offers a population health software product that interfaces with more than 200 home health and medical devices, allowing medical providers to view, manage, and engage with patients remotely. The software provides a comprehensive view of patient's medical profile, improving care coordination and promoting patient engagement their own health. The PHR+ software uses data analytics, trends, triggers, and rewards to personalize the patient's experience and promote engagement.

 

Medical Memory

Medical Memory is a digital health communication platform that provides secure HIPAA-compliant medical video messaging to enhance communication between providers, patients, and care givers. Their patient-centric service utilizes cloud-based technology to efficiently support a predictive-patient profiling engine and analytics to deliver enhanced experience to patients and unique data points to the healthcare industry. 

 

SMART Brain Aging

SMART Brain Aging is a health care technology company delivering research-supported programs, in-person and virtually, that reduce cognitive decline in aging brains. SMART Brain Aging provides prevention, diagnosis, and treatment of dementia through in-person and online programs featuring socialized brain training. The company offers two products:  Brain U Clinic, and Brain U Online.

 

Competition Category 3: Novel Medical Devices – Sponsored by Molded Devices

 

Axolotl Biologix (Axolotl)

Axolotl Biologix (Axolotl) is a biologics company that manufactures human cell and tissue products (HCT/P) including human amniotic fluid, human amniotic membrane patches, and human tissue harvesting kits for regenerative medicine procedures. Axolotl Biologix is able to grow multiple 4 inch by 4 inch patches of a patient’s own skin from a blood sample and a small skin sample the size of a skin mole. In addition, they are able to heal chronic wounds for diabetics. These types of wounds have historically resulted in amputation.

Sential

Sential is co-founded by four graduate students with the vision of transforming emergency care. The company’s first initiative, Endurance, focuses on improving survival and outcomes for sudden cardiac-arrest victims outside of hospitals. It is designed to provide consistent and reliable chest compressions in an automated fashion to assist emergency responders in providing better rescue and care to sudden cardiac-arrest victims.

Exomed

The QuickFix is a specialized screw designed as an intra-medullary nail with indications for treating most fractures and/or osteotomies of the metacarpals.  Modifications of the technique permit the product to repair a wide variety of types of fractures of the head, neck, shaft, and/or base of the metacarpal. The fracture type can either be transverse, oblique or comminuted based upon individual preference. While current therapies require an open incision the Quickfix is minimally invasive and doesn't require splinting.

 

Portela Soli Medical  (PSM)

Catheter-associated urinary tract infections are a $1 billion annual problem in the U.S., due to 51 million major surgeries requiring catheterization. Patients who are hospitalized for a procedure that requires a urinary catheter face increased chances of infection, sepsis, increased length of stay, and even death. PSM created a patent-pending product expected to change the standard of care and reduce hospital-acquired infections. This is an important area of focus for hospitals and doctors due to new Medicare penalties that withhold reimbursements for treatment of these infections, while requiring hospitals to pay additional penalties. This product not only may reduce the chances of infection, but also allows urologists to medicate the urinary tract – something that does not exist today.
 

Vascular Access for Hemodialysis

Vascular Access for Hemodialysis has developed an innovative solution for hemodialysis patients. Typical hemodialysis requires the use of two large needles in order to achieve the needed flow rates, but this innovative company has created a method for providing hemodialysis without creating multiple sensitive puncture sites from large gauge needles.

 

This team’s technology creates a small opening and then stretches the skin and soft tissue in order to allow access for much larger venous access tubes that are able to extract and return blood at the same time through a single access site. Fewer access sites gives each site time to heal before it is used again and a smaller opening allows the body to heal completely before a particular access site is reused. The result is less patient discomfort and improved patient outcomes due to lowering the stress and pressure on the patient’s skin, veins, and red blood cells.

 

Competition Category 4: Early Diagnosis Tools for Dementia

 

FlexBioTech

FlexBioTech Inc. delivers novel, patent-pending and peer-reviewed molecular diagnostic technology that replaces centralized clinical laboratory testing with disposable, rapid-result, point-of-care diagnostic testing. The technology adds quantitative analysis for improved diagnosis plus simultaneous assessment of multiple diseases in a fully self-contained, fully-disposable configuration, that doesn’t require a separate reader. FlexBio aims to miniaturize the functionality of today’s medical diagnostic laboratory into compact, fully-disposable, and low-cost configuration.

 

 

University Student semifinalist teams for BioAccel’s Solutions Challenge 2016

 

Competition Category 5: Regents Rivalry Award for Students – Sponsored by Medtronic

 

Student semifinalists selected for “Proof-of-Product” Pitches

 

The following university semifinalist student teams will share “proof-of-product” pitches, competing for start-up stipends to support continued progress toward company start-ups.

 

Sarver Heart Center (University of Arizona)

Cardiovascular disease is among the most common causes of death and is an epidemic in our nation. Sarver Heart Center’s laboratory developed a rat model of Chronic Heart Failure (CHF) that accurately replicates clinical conditions of ventricular tachycardia (VT), ventricular fibrillation, mechanical alternans, and pulseless electrical activity which collectively contribute to mortalities associated with Sudden Cardiac Death. This team hopes to explore the effects of well-known arrhythmogenic and anti-arrhythmogenic drugs to validate the research model’s clinical accuracy and prepare the custom software for market.

 

Assistive Shower Chair, Inc. (Arizona State University)

This student team has developed an assistive shower chair for elderly people helps the user to stand up from a sitting position. Featuring pneumatic cylinders, this assistive chair will allow an elderly person move from one area to another and can also be used to when showering or going to the bathroom. The chair will use cost-effective, durable polyurethane, aluminum, and nylon material suitable for lifting up to 300 pounds. 

 

Wrist-Based Pulse Oximeter (Arizona State University)

There is no continuously wearable pulse oximeter available to children. This creates a stressful situation for parents of children with severe respiratory diseases, particularly while the child is sleeping. This also prevents children with severe respiratory diseases from participating in physical activity due to fears of overexertion.

This team has developed a wearable, wrist-based pulse oximeter to be used in monitoring and tracking the health state of children suffering from respiratory related diseases or illnesses. Unlike current devices on the market, the Wrist-Based Pulse Oximeter provides a discrete, pediatric-specific, continuous monitoring system that is affordable without insurance and available without prescription.

 

Fishbone Prosthetic (Arizona State University)

The Fishbone Prosthetic is a myoelectric, press-fit transradial hand and arm prosthetic that will be made using advanced manufacturing techniques. The mechanical design allows it to withstand large compression, torsional, and bending forces while also allowing for failure before harm can be done to the user. This mechanical design is referred to as Fishbone, and is in the process of getting patented. The use of novel components in this device will yield a light-weight and low-cost prosthetic. This technology will be applicable to other types of prosthetics once it is fully developed.

 

K9 BioWalk  (University of California – Irvine team)

K9 BioWalk is creating prosthetic legs for both dogs with underdeveloped limbs and dogs with total limb amputation. The prosthesis can be customized using 3D printing from durable filament. However, dogs requiring total limb amputation will have a standard design prosthesis scaled to fit the dog. The prosthesis includes interchangeable treads and sensor technology to ensure that the dog is comfortable when using the prosthesis.

 

Syntr Health Technologies (University of California – Irvine team)

Compared to current methods of obtaining stem cells from adipose tissue (fat), the Syntr Health Technologies device puts a new spin on the competition by providing a faster, easier and minimally processed method of obtaining the inherent regenerative cells. Syntrfuge™ a CD-LOC Device utilizes a combination of centrifugal design (CD) and lab-on-a-chip microfluidics to dissociate and activate the native stem cells in fat tissue. This fully automated system will allow for easy use by doctors or technicians in the hospital or clinic setting. With no chemical additives, our device ensures low risk to the patient and minimal manipulation of stem cells.

 

Competition Category 5: Regents Rivalry Award for Students – Sponsored by Medtronic

 

Student semifinalists selected for “Quick Concept” Pitches

The following university semifinalist student teams will share two-minute innovation “quick concept” pitches for Scorpion feedback and potential start-up stipends to support continued progress toward company start-ups.

 

Handlehealth.Tech (Grand Canyon University)

We want to improve everyday health by using preventative sheath to prevent the spread of many diseases that hands touch. With a copper-type, antimicrobial material, our job is to enhance a preventive technique to save you money, and save lives.

 

VR4Happiness (University of Arizona)

This team is developing a high-fidelity, immersive virtual reality therapeutics platform that allows patients, practitioners, and family members an unprecedented understanding of their disease state. The technology will place the subject in a virtual world or situation that is tailored to the subject’s specific disease state or treatment plan, allowing the subject to become an active participant in the virtual world. The system will comprise a set of virtual reality goggles capable of connecting to a cloud server with security built into the system.

 

Sapio (Arizona State University)

Our technology, "The QuickCheck", is a simple wrist watch that has all the components a type II diabetic person needs in order to monitor their blood glucose levels. This includes a glucometer, a lancet and test strips. Not only does include those item in it but the QuickCheck also will also be a functioning smart watch that includes Bluetooth capabilities and a touch screen.

 

Stepplus (Arizona State University)

We will develop a wearable device that provides auditory, visual, and haptic feedback through a smartphone application, recording daily progress and transmitting a concise report to the neurologist or physical therapist. This rehabilitation technology would be the first on the market to track and provide feedback on step length. By making Parkinson's disease (PD) patients more aware of their abnormal step lengths, Stepplus aims to decrease the likelihood of falls for this population.

 

Phokas (University of California – Irvine)

Phokas hopes to enhance real-time data during endoscopic procedures. A traditional endoscope provides a white light, a lens system, and a camera for diagnosis and possible surgical procedures.  The endoscope has lacked the ability to detect anything under the surface of a typical subject, yielding often insufficient data for whether there are clear indications of a symptom or not.  Phokas will implement a blood flow sensing endoscope that is low cost and, ideally, single-use based.

 

Velox Biosystems 180 (University of California – Irvine team)

This team’s product, GenoBot, will be the first one-stop, sample-to-result antibiotic resistant bacteria genotype screening system for rapid point-of-care diagnostics. The sensitivity of the system is in the single bacterium level, which allows analysis of early-stage bacterial infections in a rapid, sensitive, portable, and low-cost manner.

 

Mindstruct (University of California – Irvine)

Mindstruct is developing a final three-dimensional mode of visualizing the epileptic brain prior to surgery. This team plans to use both structural and functional information that doctors can currently attain from MRI and CT scans combined with electrode matrices. A 3D virtual model will be developed by piecing together slices from both MRI and CT scans to give a full picture of brain structures.

 

Sensenium Medical (University of California – Irvine)

Sensenium Medical is improving stroke analysis, addressing the time required to differentiate between a hemorrhage and an occlusion-caused stroke. This team is developing a handheld critical-care device that is able to effectively and accurately detect intracranial hemorrhages. Being a critical-care technology, this device can be used in the ambulance and in an emergency situation. It will also be easy to use and easy to read. Instead of creating an image of the brain that then needs to be inspected by doctors, the device will produce a positive/negative reading to identify the presence/absence of a hemorrhage. This will allow the device to be used by anyone, not just trained medical professionals.

 

###

Solutions Challenge 2016 Competition Category Descriptions

For the 2016 Solutions Challenge, special consideration will be given to ventures that in addition to addressing one of the Challenge Categories below, also positively affect, impact or focus on behavioral/mental health patients and aging populations. 

Digital, Wearable and Mobile Health – Sponsored by Life 365

The estimated CAGR of the digital and mobile health markets from 2015-2020 is 18 percent and 20 percent respectively[1],[2]. This rapid growth can be leveraged to direct personalized care, improve patient engagement, streamline workflow, and create data that can be utilized to influence patient and clinical behavior.  These factors play an important role in the changing reimbursement environment heavily weighting outcomes and performance. BioAccel welcomes digital wearable and mobile solutions that engage patients and clinicians to improve outcomes and ultimately reduce overall healthcare expenditures.

Regents Rivalry Award for Students – Sponsored by Medtronic (Two divisions: Proof of Product, and Quick Concept Pitches)

Developing the next generation of biomedical entrepreneurs is critical to sustainability and success of the biomedical industry. BioAccel opened this category to any and all medical technologies originating from current or recently graduated student teams.

Coordinated Care – Sponsored by Celgene

Coordinated care among individuals with complex or multiple chronic diseases is critical to obtaining the outcomes required by the pay for performance reimbursement model.  Because of this, technologies and business models that facilitate coordinated and continuous care are a hot topic in healthcare today.  Coordinated care is driving the need for technologies that improve communication between clinical specialists, increase the interoperability of electronic health records (EHRs and electronic medical records (EMRs). These technologies have potential to support professionals such as “Healthcare Navigators” ensure coordinated and continuous health care is delivered.  BioAccel invites entrepreneurs addressing coordinated care through technology to compete in this year’s solutions challenge. Ventures providing tools for Healthcare Navigators are highly needed and will be given special consideration.

Novel Medical Devices – Sponsored by Molded Devices

Medical devices are a staple in clinical care, and the current worldwide market for devices has surpassed $380 billion annually[3].  Although growth continues, markets in the US and other developed areas are reaching maturity and have increasing pressure from reimbursement and taxation.  The medical device industry is trending towards mergers and emerging markets to reach revenue targets.  The next generation of medical devices must not only improve clinical outcomes, but do so while reducing overall treatment costs, adding utility to mature device markets.  Medical device ventures that demonstrate these characteristics are eligible for Solutions Challenge 2016.   

Early Diagnosis Tools for Dementia

Dementia often goes undiagnosed for too long. Banner Health is looking for an explicitly simple standalone mobile device application to provide cognitive screening to help patients and caregivers to be proactive in gathering practical information prior to a doctor’s visit. This application would serve to gather information about the patient’s ability to manage instrumental activities of independent daily living and signify if further cognitive evaluation is needed.

 

###

 

BioAccel’s Scorpions for Solutions Challenge 2016

 

The following nine leaders will serve as “Scorpion” judges and potential investors, making a minimum investment each of $10,000, to support winning med-tech companies and concepts.

 

Dirk Karsten Beth, Hyalescent Ventures Founder and Managing Director

 

Alex Brigham, Ethisphere Institute CEO

 

Todd Davis, Lifelock Founder and Executive Vice Chairman of the Board

 

David Hetz, Cain Brothers Vice Chairman

 

Larry Heitz, Investor and Business Owner

 

Vishu Jhaveri, M.D., M.S.A., Blue Cross Blue Shield of Arizona Senior Vice President of Health Services and Chief Medical Officer, and CEO of Blue Cross Blue Shield of Arizona's investment subsidiary, Trinnovate Ventures

 

Matt Likens, Ulthera Founder and former CEO, and investor

 

Jeff Pruitt, Tallwave Founder and CEO

 

Laura J. Zeman-Mullen, Patent Attorney |Zeman-Mullen & Ford, LLP

 

###

 

About Solutions Challenge 2016

BioAccel’s premiere event, Solutions Challenge, is scheduled for Thursday, December 1, 2016 from 1 p.m. to 8 p.m. at Phoenix Theatre. Competition begins at 1 p.m., with a reception at 4:30 p.m. followed by award announcements and a post-award celebration.

 

 For more information, go to (http://bioaccel.org/program/solutions-challenge).

 

Tickets and sponsor information for the Solutions Challenge Scorpion Pit competition and award reception are on online at http://bit.ly/2exaHWF.

 

The BioAccel Solutions Challenge is an exciting, annual program where current healthcare needs are identified and solicited as challenge categories to entrepreneurs in the region. 

About BioAccel

 

BioAccel is a leading organization in the United States dedicated to developing a robust medtech ecosystem including entrepreneur development, and creation of a validated pipeline of commercially viable medical technology to transform healthcare delivery. Our mission is to work with qualifying entrepreneurs and their early-stage companies to identify start-up funding, as well as provide training and mentorship to accelerate commercialization, improve healthcare through innovation, and diversify economic development.

Since inception in 2009, BioAccel has supported the launch of 17 game-changing healthcare device companies, filling an unmet need in Arizona’s emerging bioscience sector. BioAccel has helped its bioscience entrepreneurs successfully navigate the “Valley of Death” while creating healthy communities through vanguard solutions that support Arizona economic growth.

 

All BioAccel programs are dedicated to achieving our mission:  To work with qualifying entrepreneurs and their early-stage bioscience technology and medical device companies to identify start-up funding, as well as provide training and mentorship to accelerate commercialization, improve healthcare through innovation, and diversify economic development.

 

###

 

 

 

[1] (Wearable Medical Devices, 2015)

[2] (mhealth Markets Worldwide, 2015)

[3] (Global Market for Medical Devices, 6th Ed., 2015)